azathioprine and valganciclovir

azathioprine has been researched along with valganciclovir in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cheung, WW; Hwang, GY; Kwong, YL; Tse, E1
Dickson, M; Eliadou, E; Ferguson, P; Goossens, L; Stace, NH; Weinkove, R1
Cabré, E; Cañete, F; Clos-Parals, A; Domènech, E; Fumagalli, C; Garcia-Planella, E; Gordillo, J; Guardiola, J; José Paúles, M; Llaó, J; Mañosa, M; Ojanguren, I; Rodríguez-Martínez, P; Ruiz-Cerulla, A1
Bahadur, MM; Dhope, N; Shingare, A1

Reviews

1 review(s) available for azathioprine and valganciclovir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for azathioprine and valganciclovir

ArticleYear
Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
    Haematologica, 2006, Volume: 91, Issue:5 Suppl

    Topics: Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antiviral Agents; Azathioprine; Blood Transfusion; CD52 Antigen; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Ganciclovir; Glycoproteins; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Remission Induction; Rituximab; Splenectomy; Valganciclovir; Viremia; Virus Activation

2006
Fever and pancytopenia in a patient with Crohn's disease.
    Gut, 2013, Volume: 62, Issue:9

    Topics: Angiography; Antiviral Agents; Azathioprine; Cecum; Crohn Disease; Digestive System Surgical Procedures; Disease Progression; Female; Fever; Foscarnet; Ganciclovir; Gastrointestinal Hemorrhage; Humans; Ileitis; Ileum; Immunosuppression Therapy; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Pancytopenia; Rectum; Treatment Outcome; Valganciclovir; Young Adult

2013
Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Journal of Crohn's & colitis, 2019, Mar-26, Volume: 13, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Antiviral Agents; Azathioprine; Colectomy; Colitis, Ulcerative; Colon; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Tumor Necrosis Factor-alpha; Valganciclovir; Virus Activation

2019
Novel risk factor for valganciclovir toxicity-NUDT15 genetic variant.
    Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:2

    Topics: Azathioprine; Humans; Leukopenia; Pyrophosphatases; Risk Factors; Valganciclovir

2022